Skip to main content
Premium Trial:

Request an Annual Quote

Vantari Genetics, Translational Software to Genotype Patients for Alzheimer's Research Program

NEW YORK (GenomeWeb) – Vantari Genetics and Translational Software (TSI) have partnered to provide genotype testing, actionable genomic information, and custom reporting to support the Banner Alzheimer's Institute's GeneMatch registry.

GeneMatch is a national program that uses genetic testing information to recruit participants for Alzheimer's prevention studies.

As part of their collaboration, Vantari and TSI will provide testing for the apolipoprotein E (APOE) gene using cheek swabs of volunteers interested in participating in community-based Alzheimer's research opportunities. The partners will analyze the genomic data to provide scientific intelligence about the genetic variants of volunteers, which is used to identify study participants at varying degrees of genetic risk for developing Alzheimer's to match them to available research studies.

Vantari, based in Irvine, California, is a high-complexity CLIA-certified laboratory offering clinical diagnostics, genetic testing, and contract research services. Bellevue, Washington-based TSI provides pharmacogenomic decision support through its PGx knowledgebase and Fast Healthcare Interoperability Resource-based API.